rs587776693
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001127222.2(CACNA1A):c.3989+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001127222.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- episodic ataxia type 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
- developmental and epileptic encephalopathy, 42Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- migraine, familial hemiplegic, 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spinocerebellar ataxia type 6Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- benign paroxysmal torticollis of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial or sporadic hemiplegic migraineInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lennox-Gastaut syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1A | NM_001127222.2 | c.3989+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | ENST00000360228.11 | NP_001120694.1 | ||
| CACNA1A | NM_001127221.2 | c.3992+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | ENST00000638009.2 | NP_001120693.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1A | ENST00000360228.11 | c.3989+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | 1 | NM_001127222.2 | ENSP00000353362.5 | |||
| CACNA1A | ENST00000638009.2 | c.3992+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | 1 | NM_001127221.2 | ENSP00000489913.1 | |||
| CACNA1A | ENST00000638029.1 | c.4001+1G>T | splice_donor_variant, intron_variant | Intron 24 of 47 | 5 | ENSP00000489829.1 | ||||
| CACNA1A | ENST00000573710.7 | c.3995+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | 5 | ENSP00000460092.3 | ||||
| CACNA1A | ENST00000635727.1 | c.3992+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | 5 | ENSP00000490001.1 | ||||
| CACNA1A | ENST00000637769.1 | c.3992+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | 1 | ENSP00000489778.1 | ||||
| CACNA1A | ENST00000636012.1 | c.3992+1G>T | splice_donor_variant, intron_variant | Intron 24 of 45 | 5 | ENSP00000490223.1 | ||||
| CACNA1A | ENST00000637736.1 | c.3851+1G>T | splice_donor_variant, intron_variant | Intron 23 of 45 | 5 | ENSP00000489861.1 | ||||
| CACNA1A | ENST00000636389.1 | c.3992+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | 5 | ENSP00000489992.1 | ||||
| CACNA1A | ENST00000637432.1 | c.4001+1G>T | splice_donor_variant, intron_variant | Intron 24 of 47 | 5 | ENSP00000490617.1 | ||||
| CACNA1A | ENST00000636549.1 | c.3992+1G>T | splice_donor_variant, intron_variant | Intron 24 of 47 | 5 | ENSP00000490578.1 | ||||
| CACNA1A | ENST00000637927.1 | c.3995+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | 5 | ENSP00000489715.1 | ||||
| CACNA1A | ENST00000635895.1 | c.3992+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | 5 | ENSP00000490323.1 | ||||
| CACNA1A | ENST00000637276.1 | c.3992+1G>T | splice_donor_variant, intron_variant | Intron 24 of 45 | 5 | ENSP00000489777.1 | ||||
| CACNA1A | ENST00000636768.2 | n.3992+1G>T | splice_donor_variant, intron_variant | Intron 24 of 44 | 5 | ENSP00000490190.2 | ||||
| CACNA1A | ENST00000713789.1 | n.3989+1G>T | splice_donor_variant, intron_variant | Intron 24 of 46 | ENSP00000519091.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Disruption of this splice site has been observed in individuals with episodic ataxia type 2 (PMID: 8898206, 22942164). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 24 of the CACNA1A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CACNA1A are known to be pathogenic (PMID: 10371528, 19486177, 25735478, 27250579).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at